Cargando…
Treatment Outcome of Patients with Buruli Ulcer Disease in Togo
BACKGROUND: Following introduction of antimycobacterial treatment of Buruli ulcer disease (BUD), several clinical studies evaluated treatment outcomes of BUD patients, in particular healing times, secondary lesions and functional limitations. Whereas recurrences were rarely observed, paradoxical rea...
Autores principales: | Beissner, Marcus, Arens, Nathalie, Wiedemann, Franz, Piten, Ebekalisaï, Kobara, Basile, Bauer, Malkin, Herbinger, Karl-Heinz, Badziklou, Kossi, Banla Kere, Abiba, Löscher, Thomas, Nitschke, Jörg, Bretzel, Gisela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608783/ https://www.ncbi.nlm.nih.gov/pubmed/26474069 http://dx.doi.org/10.1371/journal.pntd.0004170 |
Ejemplares similares
-
Laboratory Confirmation of Buruli Ulcer Disease in Togo, 2007–2010
por: Bretzel, Gisela, et al.
Publicado: (2011) -
Spontaneous Clearance of a Secondary Buruli Ulcer Lesion Emerging Ten Months after Completion of Chemotherapy—A Case Report from Togo
por: Beissner, Marcus, et al.
Publicado: (2012) -
Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region
por: Maman, Issaka, et al.
Publicado: (2018) -
Implementation of a National Reference Laboratory for Buruli Ulcer Disease in Togo
por: Beissner, Marcus, et al.
Publicado: (2013) -
Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
por: Phillips, Richard Odame, et al.
Publicado: (2015)